Table 8.

Incidence of adverse drug reactions (ADRs) reported in the safety analysis population (n = 2,590)

Parameter	n [%]
No. of patients who developed an ADR	81 [3.13]
Total no. of ADRsa	103
No. of ADRsa commonly associated with calcium antagonists	34
Dizziness	13 [0.50]
Headache	8 [0.31]
Palpitations	5 [0.19]
Hot flushes	4 [0.15]
Edema	4 [0.15]

^aThese ADRs are classified according to their Medical Dictionary for Regulatory Activities (MedDRA) Preferred Terms